Lightning Rx, Colette Nataf
press clippingspodcast
Podcast: Lightning Rx' Colette Nataf interviews CEO Heltzen on future of biomanufacturingOctober 22, 2025
Podcast: 'The Catalyst' interviews CEO, Michael Heltzen
heltzenpress clippingsvideopodcast
Podcast: 'The Catalyst' interviews CEO, Michael HeltzenOctober 17, 2025
Zachary Karl, Vice President Business Development @ Bio Innovations Midwest 2025
press clippingsvideo
World Bio Markets: AI - A tool U.S. industrial biomanufacturing cannot ignoreOctober 8, 2025
Inside Biotech podcast interviews CEO, Michael Heltzen
heltzenpress clippingsvideopodcast
Podcast: 'Inside Biotech' interviews CEO, Michael HeltzenOctober 2, 2025
CCO Damien Perriman and co-founder and VP of Development, Dr. Paul Opgenorth.
press releasescienceperriman
Driving the cell-free revolution: eXoZymes leaders join BioMADE Leadership & Technical CommitteesSeptember 30, 2025
MDB Capital: eXoZymes & NCTx: The Breakthrough Opportunity with NCTx and Treating a Global Health Epidemic
heltzeninvestorpress clippingsvideo
MDB Capital: eXoZymes & NCTx: The Breakthrough Opportunity with NCTx and Treating a Global Health EpidemicSeptember 18, 2025
The challenges of SynBio
video
The challenges of SynBioSeptember 15, 2025
ARCHIVE: Transcript - Q2 2025 Earnings Call
investorvideoARCHIVE
ARCHIVE: Transcript - Q2 2025 Earnings CallAugust 13, 2025
ARCHIVE: eXoZymes provides second quarter 2025 update at 5PM EST today
press releaseinvestorARCHIVE
ARCHIVE: eXoZymes provides second quarter 2025 update at 5PM EST todayAugust 12, 2025
ARCHIVE: eXoZymes to host second quarter 2025 update on Tuesday August 12, 2025, at 5PM EST
press releaseinvestorARCHIVE
ARCHIVE: eXoZymes to host second quarter 2025 update on Tuesday August 12, 2025, at 5PM ESTAugust 7, 2025
Previous page
Page 7 of 14
Next page